1. Outcome of diffuse large B‐cell lymphoma in patients over the age of 70 years: Real‐world experience in a large U.K. district general hospital. (June 2017) Authors: Addada, J.; Bryan, A.; Lala, J.; Millar, C.; Fellows, G.; Smith, A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. POLATUZUMAB VEDOTIN WITH BENDAMUSTINE AND RITUXIMAB FOR RELAPSED/REFRACTORY HIGH‐GRADE B‐CELL LYMPHOMA: THE UK EXPERIENCE. (17th June 2021) Authors: Northend, M.; Wilson, W.; Osborne, W.; Fox, C. P.; Davies, A. J; El‐Sharkawi, D.; Phillips, E. H.; Sim, H. W.; Sadullah, S.; Shah, N.; Peng, Y. Y.; Qureshi, I.; Addada, J.; Mora, R. F.; Phillips, N.; Kuhnl, A.; Davies, E.; Wrench, D.; McKay, P.; Karpha, I. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗